Fluocinolone Acetonide

ANI Pharmaceuticals will acquire Alimera Sciences under the terms of a definitive agreement, according to a press release.

WAILEA, Hawaii — In this Healio Video Perspective from Retina 2024, Samuel A. Minaker, MD, discusses the 0.19 mg fluocinolone acetonide implant for diabetic macular edema.

In this Healio Video Perspective, David Almeida, MD, MBA, PhD, speaks about real-world study results of the fluocinolone acetonide intravitreal implant, a long-acting drug delivery system for diabetic macular edema.

Combining the corticosteroid fluocinolone acetonide with ciprofloxacin was safe and efficacious in treating swimmer’s ear, although it was not superior to treatment with either agent alone, according to a study published in JAMA Network Open.

WAIKOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2022, Mike Padilla, vice president of marketing at Alimera Sciences, discusses several trials.

WAILEA, Hawaii — In this video from Retina 2021, Caesar K. Luo, MD, discusses an analysis investigating patients with diabetic retinopathy and fluocinolone acetonide implant who were lost to follow-up compared with anti-VEGF monotherapy.

In this episode, Rick Eiswirth, president and CEO of Alimera Sciences, shares the latest on the phase 4 New Day study of Iluvien, as well as his predictions for the future of ophthalmology.

A real-world efficacy study of EyePoint Pharmaceuticals’ Yutiq fluocinolone implant in eyes with chronic noninfectious uveitis demonstrated stable visual acuity trending toward improvement at 6 months, according to a presenter.

In this Healio Video Perspective from the virtual Eyecelerator conference, Rick Eiswirth, president and CEO of Alimera Sciences, discusses clinical data for Iluvien to treat diabetic macular edema, as well as plans for the NEW DAY study.

The Scottish Medicines Consortium has accepted Iluvien for prevention of relapse in recurrent noninfectious posterior segment uveitis, Alimera announced in a press release.